UK markets open in 7 hours 53 minutes

Theravance Biopharma, Inc. (TBPH)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.49-0.05 (-0.52%)
At close: 04:00PM EDT
9.41 -0.08 (-0.84%)
After hours: 04:05PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-55,193
-55,193
872,132
-199,426
-278,017
Depreciation & amortisation
4,256
4,256
7,024
8,598
6,972
Deferred income taxes
3,207
3,207
0
-
-
Stock-based compensation
25,371
25,371
39,734
62,061
62,976
Change in working capital
-8,340
-8,340
42,350
-39,549
-37,777
Accounts receivable
-689
-689
-2,720
1,803
6,128
Inventory
-
-
-
-
0
Accounts payable
6
6
-1,612
-3,534
3,658
Other working capital
-29,485
-29,485
-187,563
-211,264
-257,019
Other non-cash items
2,350
2,350
974
-1,853
-95
Net cash provided by operating activities
-26,997
-26,997
-186,991
-207,858
-250,403
Cash flows from investing activities
Investments in property, plant and equipment
-2,488
-2,488
-572
-3,406
-6,616
Purchases of investments
-134,534
-134,534
-103,145
-158,305
-401,987
Sales/maturities of investments
102,812
102,812
158,017
286,199
419,260
Other investing activities
-
-
2,709
-
-
Net cash used for investing activities
-32,697
-32,697
1,154,009
124,494
10,721
Cash flows from financing activities
Debt repayment
0
0
-631,603
-10,730
-235,347
Common stock issued
-
-
0
108,180
139,915
Common stock repurchased
-199,551
-199,551
-132,280
-9,061
-9,749
Other financing activities
-
-
24,464
-
-5,326
Net cash used provided by (used for) financing activities
-198,933
-198,933
-738,617
91,860
279,881
Net change in cash
-258,627
-258,627
208,212
8,496
23,403
Cash at beginning of period
299,008
299,008
90,796
82,300
58,897
Cash at end of period
40,381
40,381
299,008
90,796
82,300
Free cash flow
Operating cash flow
-26,997
-26,997
-186,991
-207,858
-250,403
Capital expenditure
-2,488
-2,488
-572
-3,406
-6,616
Free cash flow
-29,485
-29,485
-187,563
-211,264
-257,019